AGNPF (Grey Matters Health) Stock Based Compensation: $0.00 Mil (TTM As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AGNPF Grey Matters Health Inc AGNPF
30 GF Score
Price $0.29
! 1 Warning Sign
View Full Analysis

What is Grey Matters Health Stock Based Compensation?

Grey Matters Health AGNPF +4.89% 30 Stock Based Compensation is $0.00 Mil as of Feb. 2026. GuruFocus rates AGNPF with a GF Score™ of 30/100. The stock has 1 warning sign investors should review.

Grey Matters Health's Stock Based Compensation for the three months ended in Feb. 2026 was $0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Feb. 2026 was $0.00 Mil.

Grey Matters Health Stock Based Compensation Related Terms

Grey Matters Health Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Grey Matters Health's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grey Matters Health Stock Based Compensation Chart

Grey Matters Health Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.66 0.41 0.93 0.21 0.14

Grey Matters Health Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
AGNPF
30GF Score
Grey Matters Health Inc AGNPF
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Grey Matters Health Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

What does a Stock Based Compensation of $0.00 Mil mean?
Grey Matters Health (AGNPF) has a Stock Based Compensation of $0.00 Mil as of Feb. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Grey Matters Health and its competitors.
Is Grey Matters Health's Stock Based Compensation too high?
Grey Matters Health's current Stock Based Compensation is $0.00 Mil. Overall, Grey Matters Health has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Grey Matters Health's Stock Based Compensation compare to VRTX and REGN?
Grey Matters Health's Stock Based Compensation of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Biotechnology company?
A good Stock Based Compensation depends on the Biotechnology industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Grey Matters Health and its competitors. Grey Matters Health's current Stock Based Compensation is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grey Matters Health stock overvalued right now?
Grey Matters Health (AGNPF) has a current Stock Based Compensation of $0.00 Mil. The current Stock Based Compensation is $0.00 Mil. Grey Matters Health's overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Grey Matters Health (AGNPF), the current Stock Based Compensation is $0.00 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Grey Matters Health Business Description

Other Exchanges GREY:Canada
Address 601 West Broadway, Suite 400, Vancouver, BC, CAN, V5Z 4C2
Grey Matters Health Inc is a drug repurposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations, and seeking new regulatory approvals in world-wide markets.
30GF Score

Get the complete analysis for AGNPF

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.29
Price